ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1900

Capturing Patient Cohorts: A Temporal Arteritis Classifier

Megan Sullivan1, Joseph Rosen1, Christopher Grilli1, Kenneth Warrington2 and Victor E Ortega1, 1Mayo Clinic Arizona, Scottsdale, AZ, 2Mayo Clinic, ROCHESTER, MN

Meeting: ACR Convergence 2025

Keywords: Data Management, Diagnostic criteria, giant cell arteritis, population studies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1877–1913) Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Giant cell arteritis (GCA) is a granulomatous vasculitis affecting cranial and large arteries in individuals over 50 years of age. Its relative rarity poses challenges for large-scale study. Institutional electronic medical record (EMR) datasets offer opportunities to examine GCA at scale but are often hindered by unstructured data formats. To address this, we developed a natural language processing (NLP) pipeline to classify temporal artery biopsy reports as positive or negative for arteritis.

Methods: Patients seen within our tri-site single-center institution with an ICD code consistent with GCA or polymyalgia rheumatica were identified. Temporal artery biopsy impression statements authored by pathologists were extracted and preprocessed using a custom regular expression script to remove Rich Text Formatting, standardize punctuation, and convert text to lowercase. These statements were then tokenized and input into a fine-tuned ClinicalBERT model1 (MedicalAI, Hugging Face). The dataset was split 80:20 into training and testing sets, with further subdivision of the training set for validation. The dataset used to train the model consisted of 349 negative and 137 positive samples. “Healed arteritis” in the report was considered a negative biopsy result. Data augmentation was implemented following initial training with 5 augmented impression reports added to the training dataset to enhance model performance. Discrimination performance was assessed using the area under the receiver operating characteristic curve (AUC).

Results: The validation cohort, consisting of 320 patient records (30 positive entries and 290 negatives), was able to provide significant discrimination of positive temporal artery biopsies with an area under the curve of 0.97 (Figure 1), accuracy of 98%, precision of 96%, and recall of 87%. Of the predictions, 315/320 (98.4%) were correct. This amounted to 5 misclassifications within the dataset, which included 1 false positive and 4 false negatives (Table 1).

Conclusion: Fine-tuned language models trained on clinical text can accurately classify pathology reports, offering a scalable approach to identifying specific diagnoses within large EMR datasets. This method improves the accuracy and utility of cohort identification for rare conditions such as GCA, supporting future research efforts.References:1. 1. K. Huang, J. Altosaar, R. Ranganath, ClinicalBERT: Modeling Clinical Notes and Predicting Hospital Readmission, in: CHIL ’20 Workshop: ACM Conference on Health, Inference, and Learning 2020, Toronto, 2020.

Supporting image 1

Supporting image 2


Disclosures: M. Sullivan: None; J. Rosen: None; C. Grilli: None; K. Warrington: Bristol-Myers Squibb(BMS), 5, Sanofi, 2; V. Ortega: None.

To cite this abstract in AMA style:

Sullivan M, Rosen J, Grilli C, Warrington K, Ortega V. Capturing Patient Cohorts: A Temporal Arteritis Classifier [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/capturing-patient-cohorts-a-temporal-arteritis-classifier/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/capturing-patient-cohorts-a-temporal-arteritis-classifier/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology